At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 520 enrolled
Drug / intervention
Accelerated partial breast irradiation (APBI) +1 moreradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomised Phase 3 Trial Of Accelerated Partial Breast Irradiation Using Intensity Modulated Radiotherapy Versus Whole Breast Irradiation
In Brief
A Phase 3 clinical trial evaluating Accelerated partial breast irradiation (APBI) and Whole breast irradiation (WBI) for Breast Cancer. Completed, enrolled 520 participants.
Detailed Summary
The aim of this Phase 3 randomised trial is to compare the efficacy and safety of whole breast radiotherapy to accelerated partial breast irradiation using intensity-modulated radiotherapy technique in selected early breast cancer patients after breast conserving surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
Countries--
Collaborators--
Timeline
Phase 3CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMar 2005
Primary CompletionJun 2013
Study CompletionFeb 2014
First PostedApr 2014
TodayJul 2026
First PostedApr 7, 2014
Enrollment StartMar 1, 2005
Primary CompletionJun 1, 2013
Study CompletionFeb 1, 2014
TodayJul 2, 2026
Enrollment to primary: 8.3 yearsPosted 12.2 years ago
Interventions
Accelerated partial breast irradiation (APBI)radiation
Accelerated partial breast irradiation (APBI) using intensity modulated radiotherapy (IMRT)
Whole breast irradiation (WBI)radiation
Conventional whole breast irradiation (WBI)